Articles

Arthritis Research & Therapy publishes selected collections of research articles, conference proceedings, reviews and reports as supplements, which are free to access online. All articles published in supplements are subject to peer review; meeting abstracts undergo review and selection by the conference. Find out more about publishing a supplement with BioMed Central.

Volume 13 Supplement 1

The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances

Reviews

Edited by Joachim Kalden

Publication of this supplement is sponsored by Merck & Company, Inc, Whitehouse Station, New Jersey, USA.

Anti-TNF therapy: what have we learned in 12 years?

Joachim R Kalden Arthritis Research & Therapy 2011, 13(Suppl 1):S1 (25 May 2011)

Full text | PDF | PubMed

Infliximab: 12 years of experience

Josef S Smolen, Paul Emery Arthritis Research & Therapy 2011, 13(Suppl 1):S2 (25 May 2011)

Abstract | Full text | PDF | PubMed

Understanding emerging treatment paradigms in rheumatoid arthritis

Ferdinand C Breedveld, Bernard Combe Arthritis Research & Therapy 2011, 13(Suppl 1):S3 (25 May 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future

Georg Schett, Laura C Coates, Zoe R Ash, Stefanie Finzel, Phillip G Conaghan Arthritis Research & Therapy 2011, 13(Suppl 1):S4 (25 May 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Advances in rheumatology: new targeted therapeutics

Paul P Tak, Joachim R Kalden Arthritis Research & Therapy 2011, 13(Suppl 1):S5 (25 May 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central